Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Personalizing Your GLP-1 Therapy with PlexusDx Genetic Testing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR, and FTO (rs9939609) variants that relate to GLP-1 and related signaling pathways
Up to 75% of daily growth hormone release occurs during sleep
The Wegovy pill has been rigorously studied through Novo Nordisk's Phase 3 OASIS clinical trial programme, which enrolled approximately 1,300 adults with obesity or overweight with one or more related health conditions
When you reach that stage, one of our team will support you in keeping your weight off for good
Clinical Evidence and Trial Findings from Current Research The key phase 2 trial (NEJM, 2023) reported mean weight reductions of up to approximately 24.2% at the highest dose over 48 weeks
US$ 21.47
US$ 21.35
US$ 24.48
US$ 25.81
US$ 28.19
US$ 22.74
US$ 22.72
US$ 21.45
